INGIBIROVANIE BIOSINTEZA KhOLESTERINA KAK TARGETNAYa TERAPIYa PRI SHH-OPOSREDOVANNYKh ONKOLOGIChESKIKh ZABOLEVANIYaKh

Open Access Open Access
Restricted Access Subscription Access

Abstract



R E Muradimova

Email: Renata.Muradimova@gmail.com

Z I Abramova

  1. Rubin L. L., de Sauvage F. J. Targeting the Hedgehog pathway in cancer // Nature Reviews Drug Discovery.- 2006.- Vol. 12.- P. 1026-1033.
  2. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma / Packer R. J., Gajjar A. J., Vezina G., Rorke-Adams L., Burger P. C., Robertson P. L. et al. // Journal of Clinical Oncology.- 2006.- Vol. 24.- P. 4202-4208.
  3. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells / Yang Z. J., Ellis T., Markant S. L., Read T. A., Kessler J. D., Bourboulas M., et al. // Cancer Cell.- 2008.- Vol. 14.- P. 135-145.
  4. Subtypes of medulloblastoma have distinct developmental origins / Gibson P., Yong T., Robinson G., Thompson M. C., Currle D. S., Eden C., et al. // Nature.- 2010.- Vol. 468.- P. 1095-1099.
  5. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma / Mulhern R. K., Palmer S. L., Merchant T. E., Wallace D., Kocak M., Brouwers P., et al. // Journal of Clinical Oncology.- 2005.- Vol. 24.- P. 5511-5519.
  6. Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response / Myers В. R., Sever N., Chong Y. C., Kim J., Belani J. D., Ruchnovsky S., et al. // Developmental Cell.- 2013.- Vol. 26 - P. 347-356.

Views

Abstract - 15

PDF (Russian) - 0

Cited-By


PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2016 Muradimova R.E., Abramova Z.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.